Remifentanil for Postoperative Pain Management After Knee Arthroscopy .
Intra-articular remifentanil on postoperative pain in knee arthroscopic surgery; a double blind randomized clinical trial.
J Orthop Sci . 2023 Sep;28(5):1082-1086.60 patients undergoing knee arthroscopy were randomized to receive either remifentanil (n=30) or saline control (n=30). The primary outcome of interest included pain at rest on a Visual Analog Scale (VAS) at 1, 3, 6, 12, 18, and 24 hours. Secondary outcomes of interest included the incidence of rescue analgesia, time to first request for analgesic, rescue analgesia consumption, total meperidine use, and the incidence of adverse events. All outcomes were significantly better in the remifentanil group compared to the saline group at all time points. No adverse events were reported in either group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
